U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06963255) titled 'Outcomes of Arterial Allografts Preserved at +2 to +8degC for Revascularization in Septic Settings' on April 30.
Brief Summary: This study does not modify patient management or treatment. All patients undergoing treatment with an arterial allograft preserved at +2/+8degC as part of an arterial revascularization in a septic environment in either of the two centers between January 2024 and January 2025 will be included.
Imaging exams and clinical follow-up data will be analyzed. Reinterventions and causes of death will be recorded. All imaging required for the 6-month follow-up is routinely performed as part of standard care. No modifi...